Skip to content
10-Q

Quarterly Report

IO Biotech, Inc. IOBTQ

0001193125-25-281820

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 10, 2025 71.95M sh
Shares Diluted Q3 2025 · Sep 30, 2025 66.94M sh
Shares Diluted Q3 2025 · Sep 30, 2025 66.24M sh
Shares Diluted Q3 2025 · Sep 30, 2024 65.88M sh
Shares Diluted Q3 2025 · Sep 30, 2024 65.88M sh
Capex Q3 2025 · Sep 30, 2025 $58K
Capex Q3 2025 · Sep 30, 2024 $33K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$61.37M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$62.72M
Long Term Debt Q3 2025 · Sep 30, 2025 $16.66M
Long Term Debt Q3 2025 · Dec 31, 2024 $0
Cash And Equivalents Q3 2025 · Sep 30, 2025 $30.66M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $60.03M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $80.19M
Stockholders Equity Q3 2025 · Sep 30, 2025 $911K
Stockholders Equity Q3 2025 · Dec 31, 2024 $47.02M
Stockholders Equity Q3 2025 · Sep 30, 2024 $72.57M
Stockholders Equity Q3 2025 · Dec 31, 2023 $133.16M
Current Liabilities Q3 2025 · Sep 30, 2025 $18.31M
Current Liabilities Q3 2025 · Dec 31, 2024 $19.49M
Total Liabilities Q3 2025 · Sep 30, 2025 $39.05M
Total Liabilities Q3 2025 · Dec 31, 2024 $20.68M
Current Assets Q3 2025 · Sep 30, 2025 $36.83M
Current Assets Q3 2025 · Dec 31, 2024 $64.95M
Total Assets Q3 2025 · Sep 30, 2025 $39.96M
Total Assets Q3 2025 · Dec 31, 2024 $67.7M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.13
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.86
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.36
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.97
Eps Basic Q3 2025 · Sep 30, 2025 −$0.13
Eps Basic Q3 2025 · Sep 30, 2025 −$0.86
Eps Basic Q3 2025 · Sep 30, 2024 −$0.36
Eps Basic Q3 2025 · Sep 30, 2024 −$0.97
Sga Expense Q3 2025 · Sep 30, 2025 $5.61M
Sga Expense Q3 2025 · Sep 30, 2025 $18.34M
Sga Expense Q3 2025 · Sep 30, 2024 $6.33M
Sga Expense Q3 2025 · Sep 30, 2024 $17.9M
Rd Expense Q3 2025 · Sep 30, 2025 $13.74M
Rd Expense Q3 2025 · Sep 30, 2025 $46.77M
Rd Expense Q3 2025 · Sep 30, 2024 $20.18M
Rd Expense Q3 2025 · Sep 30, 2024 $50.34M
Net Income Q3 2025 · Sep 30, 2025 −$8.38M
Net Income Q3 2025 · Sep 30, 2025 −$57.02M
Net Income Q3 2025 · Dec 31, 2024 −$95.5M
Net Income Q3 2025 · Sep 30, 2024 −$24.02M
Net Income Q3 2025 · Sep 30, 2024 −$64.16M
Operating Income Q3 2025 · Sep 30, 2025 −$19.36M
Operating Income Q3 2025 · Sep 30, 2025 −$65.11M
Operating Income Q3 2025 · Sep 30, 2024 −$26.5M
Operating Income Q3 2025 · Sep 30, 2024 −$68.23M